<DOC>
	<DOCNO>NCT02787161</DOCNO>
	<brief_summary>This randomize controlled clinical trial analyze impact high volume online HDF comparison high-flux HD measure physical activity .</brief_summary>
	<brief_title>Impact HemoDiaFIltration Physical Activity Self- Reported Outcomes</brief_title>
	<detailed_description>HD-FIT randomize controlled clinical trial analyze impact high volume online HDF comparison high-flux HD measure physical activity ( number step measured dialysis day ) primary endpoint . The analysis additional accelerometer data , HRQOL time recover dialysis session use exploratory outcome . The study also capture safety data , base intradialytic event , hospitalization mortality . Biochemical ( accord local requirement ) drug prescription data monitor pharma-economic analysis . Serum sample collect future analysis additional biomarkers . In summary , patient go 4 week run period high flux HD . After , patient randomize high volume online HDF continue high flux HD . Both group follow 6 month . Patients evaluate HRQOL physical activity baseline . Evaluation repeat 3 6-months . Data analyze accord intention-to-treat principle ( i.e. , accord assign instead receive treatment ) . With enrollment target 110 participant arm ( consider drop 20 % ) estimate 86 patient complete follow arm , provide trial 90 % power detect 20 % effect respect primary outcome ( predefined 20 % increase average total steps dialysis day HDF group compare HD group ) . Because nature intervention , possible blind patient , local study nurse , investigator treatment assignment . Twelve dialysis center invite participate . Each center receive two 5008S machine Cordiax dialyzer use study 10 patient center . Centralized randomization base 1:1 protocol , stratify participate center .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Patients newly treatment three time per week HD least 3 month 12 ( 18 ) month treatment ; Clinically stable accord evaluation investigator ; Kt/V &gt; 1.2 ; Patients arteriovenous fistula permanent catheter adequate flow . Age 18 year ; Life expectancy le 3 month nonrenal disease ; Participation another clinical intervention trial ; Severe incompliance regard frequency duration dialysis treatment ; Patients severe limitation mobility ( amputate , neurologic muscular disorder ) exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Hemodiafiltration</keyword>
	<keyword>Renal Replacement Therapy</keyword>
	<keyword>Physical Activity</keyword>
	<keyword>Accelerometer</keyword>
</DOC>